top of page

What Is ASCO Conference—And Should Cancer Patients Care?

Updated: 5 days ago

💡 Why ASCO Conference Matters to Patients:

Even if you’re not in the room, what happens at ASCO can shape your treatment options—now and in the future.

At ASCO, researchers present:

  • New clinical trial results

  • Updates on emerging therapies

  • Better ways to manage side effects

  • Advances in precision oncology, like KRAS-targeted therapies


🧬 For KRAS Cancer Patients:

KRAS-driven cancers (lung, colon, pancreatic, and rare cancers) are a major area of focus at ASCO. New data shared at the conference may:

  • Lead to new FDA approvals

  • Open new clinical trials

  • Offer options for patients with resistance or co-mutations


🎯 Why You Should Care about a Conference?

You don’t need to speak the science—but knowing what’s coming can help you:

  • Ask better questions

  • Stay ahead of the curve

  • Find hope in options you didn’t know existed

And that’s exactly why KRAS Kickers follows ASCO—to break it down, make it real, and help patients stay empowered.


The ASCO Annual Meeting is the world’s largest cancer conference, held every year in Chicago by the American Society of Clinical Oncology.


It brings together thousands of cancer doctors, researchers, and advocates from all over the globe to share the latest discoveries in cancer treatment, including new drugs, clinical trial results, and better ways to care for patients.


💡 Why It Matters for Patients:

  • It’s where many breakthroughs are first announced

  • Doctors learn about emerging treatments they can bring back to their patients

  • Patient advocates help make sure the focus stays on what really matters: people living with cancer



🧬 Welcome to Gen-Me Medicine

We’re entering a new era—Gen-Me Medicine—where cancer care is no longer one-size-fits-all. It’s about matching the right treatment to your unique molecular fingerprint. Clinical trials are a critical part of that future, and ASCO is where it comes to life. Insights into how to match the right treatment to the right patient.



🔬 Why ASCO Matters: Clinical Trial Updates That Could Shape Your Next Step

Every year, the ASCO Annual Meeting is where many of the most important clinical trial results in cancer research are shared for the first time.

For patients, this means:

  • 💊 New treatments may be shown to work better than current options

  • 🔄 Combination therapies may offer new hope where others didn’t

  • 🧬 Trials for specific mutations—like KRAS—are often highlighted

  • 🚀 It’s a sneak peek into what’s coming next in precision oncology


💥 KRAS Kickers Watches Closely

We attend and track trials for patients with KRAS & KRAS -focused trials so:

  • You can stay informed

  • Know what’s available now, and what’s coming soon

  • Feel confident discussing options with your doctor


🤝 You Deserve to Understand What’s Next:

KRAS Kickers attends ASCO to bring patients the most relevant highlights—because we’re here with you, turning complex science into clear, empowering information.


Video link to KRAS Cancer Trial Updates for Patients from ASCO June2025
Dr. Garassino discusses the highlight for KRAS patients from ASCO 2025 video

bottom of page